Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-007915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-01 | 2023-02-28 | LXRX | COATS LONNEL | CEO, Dir | F - Tax | $2.17 | -51.0K | 744.4K | -6% | -$110.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | COATS LONNEL | CEO, Dir | M - OptEx | — | +209.3K | 795.3K | +36% | — |
| DM | 2023-03-01 | 2023-02-28 | LXRX | COATS LONNEL | CEO, Dir | M - OptEx | — | -209.3K | 33.3K | -86% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 50,971 | $2.17 | 744,359 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-28 | M | A | 33,334 | — | 703,967 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2023-02-28 | M | A | 84,630 | — | 670,633 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2023-02-28 | M | A | 91,363 | — | 795,330 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 84,630 | — | 0 | D | — · — to — | 84,630 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 91,363 | — | 182,727 | D | — · — to — | 91,363 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 33,334 | — | 33,333 | D | — · — to — | 33,334 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |